首页> 外国专利> Rectal drug for correction of spermatogenesis disorders in male infertility

Rectal drug for correction of spermatogenesis disorders in male infertility

机译:直肠药物用于纠正男性不育症中的生精障碍

摘要

FIELD: medicine.SUBSTANCE: invention refers to medicine and represents a rectal drug for correction of spermatogenesis disorders in male infertility, containing water-soluble compounds of zinc and L-arginine and pharmaceutically acceptable carrier, presented in a form selected from a group comprising a solution or suspension enclosed in a rectal capsule or microclyster, as well as a foam, an ointment, a cream, a gel and a suppository, wherein the agent contains the following per mg therapeutic unit: L-arginine 50–250, zinc 10–50.EFFECT: use of the declared agent enables effective treatment of spermatogenesis disorders and sexual disorders, reduces viscosity of ejaculate, increases concentration of spermatozoa, increases their mobility and reduces degree of fragmentation of sperm cell DNA.5 cl, 4 tbl, 3 ex
机译:领域:本发明是指药物,并且代表一种用于矫正男性不育症中精子发生障碍的直肠药物,其包含锌和L-精氨酸的水溶性化合物和药学上可接受的载体,其形式选自包括以下物质的组:封闭在直肠胶囊或微灌肠液中的溶液或混悬液,以及泡沫,软膏,乳膏,凝胶和栓剂,其中每毫克治疗单位含有以下成分:L-精氨酸50-250,锌10- 50.效果:使用已声明的药物能够有效治疗精子发生障碍和性障碍,降低射精的粘度,增加精子的浓度,增加其活动性,并减少精子细胞DNA的碎片程度。5cl,4 tbl,3

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号